Citation:
Hsiung, Victoria; Mao, Wenhui; Udayakumar, Krishna. Issue Brief – Monkeypox: Recent Developments in the Outbreak and Lessons from the COVID-19 Pandemic. August 2022 (PDF)
Citation:
Taylor, Andrea; Biru,Blen; Udayakumar, Krishna. Creating an Evidence Engine to Drive Impact: Lessons Learned from Providing Real-Time Analysis for COVID-19 Global Response. September 2022 (PDF)
Citation:
Mao, Wenhui; Zimmerman, Armand; Urli Hodges, Elina; Ortiz, Ernesto; Dods, Galen; Taylor, Andrea; Udayakumar, Krishna. Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases. BMJ Global Health July 2023. (PDF)

Wed Apr 17 2024 - This newsletter aims to provide a central hub for information, milestones, and updates regarding the COVID Treatment QuickStart Consortium. The COVID Treatment QuickStart Consortium partners with governments to rapidly introduce and scale access to COVID-19… Read more
Citation:
Various. "A Rapid Review of COVID-19 Vaccination Roll-Out." September 5, 2022. (White paper, PDF)
Citation:
COVID Collaborative. "The COVID GAP Framework." October 15, 2021. (White paper, PDF)
Citation:
Boyer, Beth; Taylor, Andrea; Edson, Gary; Merson, Michael; McClellan, Mark; and Udayakumar, Krishna. "Holding the World to Account: Urgent Actions Needed to Close Gaps in the Global COVID-19 Response." November 18, 2021. (White paper, PDF)
Note: a summary of this study was also issued as a November 18, 2021 press release.
Citation:
Boyer, Beth; Edson, Gary; Lindstrand, Ann; Machingaidze, Shingai; McClellan, Mark; Merson, Michael; Ouma, Ahmed Ogwell; Schreiber, Benjamin; Taylor, Andrea; and Udayakumar, Krishna. "From Airports to Arms: New Insights and Urgent Recommendations to Accelerate Global COVID-19 Vaccinations." December 23, 2021. (White paper, PDF)
Citation:
Boyer, Beth; Chupp, Ethan; Edson, Gary; McClellan, Mark; Merson, Michael; Taylor, Andrea; and Udayakumar, Krishna. “Pills to People: Accelerating Equitable Global Access to Oral Therapeutics for COVID-19.” March 3, 2022. (White paper, PDF)